Treatment With Decitabine (DAC) After Azacitidine (AZA) Failure In High Risk Myelodysplastic Syndrome (MDS) and Advanced Chronic Myelomonocytic Leukemia (CMML)

被引：1
|
作者：
Braun, Thorsten
Cherait, Amina
Berthon, Celine
Willekens, Christophe
Park, Sophie
Rigal, Marthe
Brechignac, Sabine
Harel, Stephanie
Thepot, Sylvain
Quesnel, Bruno
Gardin, Claude
Ades, Lionel
Fenaux, Pierre
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2796.2796
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2796
引用
收藏
页数：2
相关论文
共 50 条
  • [41] SYSTEMATIC REVIEW OF THERAPY USED IN HIGHER-RISK (HR) MYELODYSPLASTIC SYNDROMES (MDS) AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
    Bell, J.
    Galaznik, A.
    Huelin, R.
    Stokes, M.
    Seal, B.
    Fram, R.
    Faller, D. V.
    LEUKEMIA RESEARCH, 2017, 55 : S80 - S81
  • [42] Hypomethylation induction and molecular response after decitabine therapy in chronic myelomonocytic leukemia (CMML).
    Oki, Yasuhiro
    Jelinek, Jaroslav
    Kantarjian, Hagop M.
    Issa, Jean-Pierre J.
    BLOOD, 2006, 108 (11) : 658A - 658A
  • [43] Model-based analysis to support dose selection of pevonedistat (PEV) combined with azacitidine (AZA) in patients (pts) with higher-risk myelodysplastic syndromes (MDS)/chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML).
    Zhou, Xiaofei
    Mould, Diane R.
    Zhao, Dan
    Sekeres, Mikkael A.
    Ades, Lionel
    Swords, Ronan T.
    Handa, Hiroshi
    Fram, Robert J.
    Faller, Douglas V.
    Tsukurov, Olga
    Gupta, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [44] Impact of neutropenia on the outcome of decitabine (DAC) treatment in patients (pts) with myelodysplastic syndrome (MDS).
    Pemmaraju, N.
    Kantarjian, H.
    Faderl, S.
    Garcia-Manero, G.
    Kadia, T. M.
    Borthakur, G.
    Cortes, J. E.
    Kashani, F. Ravandi
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] Outcome of Patients (pts) Treated for Myelodysplastic Syndrome (MDS) and Secondary Acute Myeloid Leukemia (s AML) After Azacitidine (AZA) Failure
    Prebet, Thomas
    Gore, Steven D.
    Esterni, Benjamin
    Itzykson, Raphael
    Thepot, Sylvain
    Beach, C. L.
    Fenaux, Pierre
    Vey, Norbert
    BLOOD, 2010, 116 (21) : 199 - 199
  • [46] UNICENTRIC EXPERIENCE IN THE COMBINED AND INDIVIDUAL USE OF AZACITIDINE AND DECITABINE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND CHRONIC MYELOMONOCYTIC LEUKEMIA
    Lerma Verdejo, A.
    Martinez Moya, M. D.
    Luts, I
    Ustariz, M., I
    Solano Ramos, F.
    HAEMATOLOGICA, 2019, 104 : 294 - 294
  • [47] Decitabine-based conditioning regimen is feasible and effective in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia
    赵小利
    China Medical Abstracts(Internal Medicine), 2019, 36 (03) : 183 - 184
  • [48] Dismal Outcome of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Azacitidine Failure in a Daily-Life Setting
    Niscola, Pasquale
    Tendas, Andrea
    Cupelli, Luca
    Giovannini, Marco
    Piccioni, Daniela
    Scaramucci, Laura
    Dentamaro, Teresa
    Del Poeta, Giovanni
    de Fabritiis, Paolo
    ACTA HAEMATOLOGICA, 2015, 133 (01) : 64 - 66
  • [49] PHASE 2 STUDY OF PEVONEDISTAT plus AZACITIDINE vs AZACITIDINE IN PATIENTS WITH HIGH-RISK MYELODISPLASIC SYNDROME (MDS), CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) OR ACUTE MYELOID LEUKEMIA (AML) <30% BLAST (NCT02610777)
    Diez, Campelo Maria
    Ades, Lionel
    Watts, Justin
    Radinoff, Atanas
    Arnan, Sangerman Montserrat
    Cerrano, Marco
    Font, Lopez Patricia
    Zeidner, Joshua
    Graux, Carlos
    Liesveld, Jane
    Selleslag, Dominik
    Tzvetkov, Nikolay
    Fram, Robert J.
    Zhao, Dan
    Bell, Jill
    Friedlander, Sharon
    Faller, Douglas V.
    Sekeres, Mikkael A.
    HAEMATOLOGICA, 2020, 105 : 71 - 72
  • [50] Oral Decitabine/Cedazuridine with Venetoclax in High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia: Analysis By Different Response Criteria
    Bataller, Alex
    Montalban-Bravo, Guillermo
    Bazinet, Alexandre
    Valero, Yesid Alvarado
    Chien, Kelly S.
    Venugopal, Sangeetha
    Ishizawa, Jo
    Hammond, Danielle E.
    Swaminathan, Mahesh
    Sasaki, Koji
    Issa, Ghayas C.
    Short, Nicholas J.
    Masarova, Lucia
    Daver, Naval
    Kadia, Tapan M.
    Colla, Simona
    Qiao, Wei
    Huang, Xuelin
    Kanagal-Shamanna, Rashmi
    Hendrickson, Stephany
    Ravandi, Farhad
    Jabbour, Elias
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    BLOOD, 2023, 142
12345